Latest news - Johnson & Johnson
2024年10月10日 · A collection of stories that highlight the way Johnson & Johnson is making an impact in the lives of its consumers, and the latest press releases from the company.
Johnson & Johnson Announces Plans to Accelerate Innovation, …
2021年11月12日 · Johnson & Johnson would Remain a Global Leader in Healthcare, Focused on Major Unmet Medical Needs and Materially Advancing Standard of Care through Biopharmaceutical and Medical Device Innovation and Technology
Press Releases - Johnson & Johnson
2 天之前 · Explore all Johnson & Johnson published press releases by date and/or topic of news.
Johnson & Johnson Announces Real-World Evidence and Phase 3 …
2021年9月21日 · Johnson & Johnson single-shot vaccine showed strong and long-lasting protection in the real world The largest real-world evidence study for a COVID-19 vaccine reported to date in the U.S. demonstrated stable vaccine effectiveness of 79 percent (CI, 77%-80%) for COVID-19-related infections and 81 percent (CI, 79%-84%) for COVID-19-related ...
Investor Relations | Johnson & Johnson
2024年10月15日 · You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact us with any questions or search this site for more information.
News | Johnson & Johnson - Investors
2024年11月18日 · You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact us with any questions or search this site for more information.
Positive New Data for Johnson & Johnson Single-Shot COVID-19 …
NEW BRUNSWICK, N.J., July 1, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced data that demonstrated its single-shot COVID-19 vaccine generated strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent SARS-CoV-2 viral variants. In addition, the data showed that the durability of the ...
Johnson & Johnson Announces 62nd Consecutive Year of …
2024年4月16日 · Johnson Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a 4.2% increase in the quarterly dividend, from $1.19 per share to $1.24 per share, marking the 62 nd year of consecutive increases.
Media Center - Johnson & Johnson
Read the latest press releases from Johnson & Johnson, find our press contacts and see our latest social media posts.
Johnson & Johnson Reports Q4 and Full-Year 2023 Results
2024年1月23日 · NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2023. “Johnson & Johnson’s full year 2023 results reflect the breadth and competitiveness of our business and our relentless focus on delivering for patients,” said Joaquin Duato, Chairman and Chief Executive Officer.